Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

ACRSACRS
Showing 4 of 11 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in ACLARIS THERAPEUTICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of ACRS (ACLARIS THERAPEUTICS INC), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1.1M

Total Shares Change

-915,509

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$1.47
0
2025-Q1
Decreased
460,842
-20.0%
$705,0880.0%$1.59
0
2024-Q4
Decreased
576,042
-37.1%
$1.4M0.0%$2.48
0
2024-Q3
New
915,509
-
$1.1M0.0%$1.17
35

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used